We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Spironolactone and Prevention of Calcineurin Inhibitor Toxicity in Kidney Transplant Recipients

This study has suspended participant recruitment.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01021943
First Posted: December 1, 2009
Last Update Posted: July 24, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Magdalena Madero, Instituto Nacional de Cardiologia Ignacio Chavez
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Study Completion Date: No date given
  Primary Completion Date: No date given